Federico Bolognani, M.D., PH.D.

Dr. Bolognani joins Axial Therapeutics with over 20 years of experience in translational neuroscience research in academia, pharmaceutical and the biotechnology industries. Most recently, [...]

Chris Meyer

Chris has more than 20 years of biopharma development experience, with an emphasis on program management, CMC, and process development.  He has built and led teams both in the US and Europe that [...]

Jeffrey Young

Mr. Young brings over 20 years of finance and capital markets experience, an extensive background in financial planning and operations, management and strategy, and a deep knowledge of the life [...]

Hitesh Bhagat, Ph.D.

Dr. Bhagat is a seasoned bio/pharmaceutical executive with 30 years of experience in full life-cycle of product development.  Dr. Bhagat has led/participated in more than 35 drug product/device [...]

Dennis Yamashita, Ph.D.

Dr. Dennis Yamashita is a highly experienced and accomplished drug hunter and medicinal chemist with extensive leadership experience at GSK and in biotech. He is co-inventor of five clinical [...]

A. Stewart Campbell, Ph.D.

Dr. Campbell joined Axial in 2016 and was appointed the company’s CEO in February 2021. Dr. Campbell has played a fundamental role in company’s growth and strategy over the last 4 years. He [...]